Clinical Trials Browser

Phase 3 × Prostatic Neoplasms × Methylprednisolone Hemisuccinate × Clear all

NCT02887976 2020-07-22

Extension of SoluMatrix TM Abiraterone Acetate in Patients Who Completed Study Number CHL-AA-201

Phase 3 Completed

Neoplasm Metastasis, Prostatic Neoplasms